Robert Miller
Family Medicine · Weatherford, TXNPI 1801892443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 204 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $964 and has fallen 98.6% since, to $14 in 2022.
Across 204 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$419
- Amarin Pharma, Inc.$264
- Supernus Pharmaceuticals, Inc.$258
- Pfizer$226
- AstraZeneca$208
- Novo Nordisk$132
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,657100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $419 |
| Amarin Pharma, Inc. | 18 | $264 |
| Supernus Pharmaceuticals, Inc. | 18 | $258 |
| Pfizer | 32 | $226 |
| AstraZeneca | 15 | $208 |
| Novo Nordisk | 9 | $132 |
| Merck | 7 | $101 |
| Amgen | 6 | $98 |
| GSK | 7 | $93 |
| Sunovion Pharmaceuticals Inc. | 7 | $85 |
| Astellas Pharma US Inc | 5 | $81 |
| Ironshore Pharmaceuticals Inc. | 2 | $76 |
| Adlon Therapeutics L.p. | 4 | $72 |
| Boehringer Ingelheim | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $51 |
| Johnson & Johnson | 4 | $48 |
| Neos Therapeutics, LP | 2 | $37 |
| Novartis | 3 | $36 |
| Genentech USA, Inc. | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Eisai Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Orexo US, Inc. | 2 | $25 |
| Currax Pharmaceuticals LLC | 2 | $23 |
| Otsuka America Pharmaceutical, Inc. | 2 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $22 |
| Lilly USA, LLC | 1 | $17 |
| Abbott | 1 | $17 |
| Dexcom, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
How this compares
$2,657 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Weatherford
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.